Toward peptide-based inhibitors as therapies for Parkinson's disease

Jody M. Mason, David P. Fairlie

OAI: oai:purehost.bath.ac.uk:publications/2587325f-c8de-4bef-8413-66c4006931b4 • DOI: https://doi.org/10.4155/fmc.15.139

ALPHA-SYNUCLEIN mimetics Drug Design Peptides Parkinson's Disease Amyloid